Literature DB >> 32243855

Amyloid Beta Secreted during Consolidation Prevents Memory Malleability.

Peter S B Finnie1, Karim Nader2.   

Abstract

Memory allows organisms to predict future events based on their prior sampling of the world. Rather than faithfully encoding each detail of related episodes, the brain is thought to incrementally construct probabilistic estimates of environmental statistics that are re-evaluated each time relevant events are encountered [1]. When faced with evidence that does not adequately fit mnemonic predictions, a process called reconsolidation can alter relevant memories to better recapitulate ongoing experience [2]. Conversely, when an ongoing event matches well-established predictions, reactivated memories tend to remain stable [3, 4]. In part, the brain may confer selective mnemonic stability by shifting cell-intrinsic mechanisms of plasticity induction [5], which could serve to constrain maladaptive updating of reliably predictive representations during anomalous events. Based on evidence of decreased cognitive flexibility and restricted synaptic plasticity in later life [6], we hypothesized that some prevalent age-associated neurobiological changes might in fact contribute to mnemonic stability [7]. Specifically, we predicted that amyloid beta (Aβ)-a peptide that often accumulates in the brains of individuals expressing senescent dementia [8-10]-is required for memory stabilization. Indeed, we observe elevated soluble Aβx-42 concentrations in the amygdala shortly after young adult rats form reconsolidation-resistant auditory fear memories. Suppressing secretases required for Aβ production immediately after learning prevents mnemonic stabilization, rendering these memories vulnerable to disruption by post-reactivation amnestic treatments. Thus, the seemingly pathogenic Aβ42 peptide may serve an adaptive physiological function during memory consolidation by engaging mechanisms that protect reliably predictive representations against subsequent modification.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; amygdala; amyloid beta; auditory fear conditioning; memory consolidation; memory reconsolidation; memory updating; metaplasticity

Year:  2020        PMID: 32243855     DOI: 10.1016/j.cub.2020.02.083

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  4 in total

1.  The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Yulan Fan; Ying Gao; Joseph Therriault; Jing Luo; Maowen Ba; Hua Zhang
Journal:  Front Aging Neurosci       Date:  2021-04-27       Impact factor: 5.750

2.  Noradrenergic projections from the locus coeruleus to the amygdala constrain fear memory reconsolidation.

Authors:  Josué Haubrich; Matteo Bernabo; Karim Nader
Journal:  Elife       Date:  2020-05-18       Impact factor: 8.140

Review 3.  Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease.

Authors:  Bhanu Chandra Karisetty; Akanksha Bhatnagar; Ellen M Armour; Mariah Beaver; Haolin Zhang; Felice Elefant
Journal:  Front Mol Neurosci       Date:  2020-11-13       Impact factor: 5.639

Review 4.  Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Authors:  Xin Yi Yeo; Grace Cunliffe; Roger C Ho; Su Seong Lee; Sangyong Jung
Journal:  Biomedicines       Date:  2022-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.